title: Interleukin-2: a double-edge sword in allogeneic stem cell transplantation.
authors: Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors: Batia
authors: B
authors: Avni
authors: Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors: Sigal
authors: S
authors: Grisariu
authors: Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors: Michael Y
authors: MY
authors: Shapira
mesh_terms: D000818:Animals; D004359:Drug Therapy, Combination; D020544:Graft vs Leukemia Effect / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D007371:Interferon-gamma / Q000276:immunology / Q000627:therapeutic use; D007376:Interleukin-2 / Q000276:immunology* / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy*; D033581:Stem Cell Transplantation; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D007376:Interleukin-2; D007371:Interferon-gamma
keywords: IL-2; alloimmunity; graft versus host disease; graft versus leukemia effect; immune modulation; immune suppression; immunotherapy; lymphokine-activated killer cells; regulatory T cells; stem cell transplantation